-transparent.png){kind=logo}
The intravenous injection of disopyramide (1.5 mg/kg) induces the return to sinus rhythm in about 60% of arrhythmias. When there exist perturbations of the cardiac rhythm, secondary to recent myocardial infarction, the percentage of success reaches 70%. The drug induces the disappearance of the extrasystoles in 80% of the cases, whatever the nature of the underlying cardiopathy. Although the secondary effects of the drug are slight, it is advisable to administer the substance in a slow intravenous injection (5 minutes), while controlling the arterial pressure and the E.C.G.
Related Publications
R Vandenbosch, and
N Lisin, and
M Andriange, and
J Gach, and
J Carlier
June 1982,
Vnitrni lekarstvi,
R Vandenbosch, and
N Lisin, and
M Andriange, and
J Gach, and
J Carlier
June 1961,
Gazzetta medica italiana,
R Vandenbosch, and
N Lisin, and
M Andriange, and
J Gach, and
J Carlier
January 1997,
Acta anaesthesiologica Scandinavica. Supplementum,
R Vandenbosch, and
N Lisin, and
M Andriange, and
J Gach, and
J Carlier
March 1995,
Mayo Clinic proceedings,
R Vandenbosch, and
N Lisin, and
M Andriange, and
J Gach, and
J Carlier
January 1970,
Antimicrobial agents and chemotherapy,
R Vandenbosch, and
N Lisin, and
M Andriange, and
J Gach, and
J Carlier
October 1972,
La Clinica terapeutica,
R Vandenbosch, and
N Lisin, and
M Andriange, and
J Gach, and
J Carlier
March 1979,
Antimicrobial agents and chemotherapy,
R Vandenbosch, and
N Lisin, and
M Andriange, and
J Gach, and
J Carlier
September 1948,
Anesthesiology,
R Vandenbosch, and
N Lisin, and
M Andriange, and
J Gach, and
J Carlier
September 1974,
Current therapeutic research, clinical and experimental,
R Vandenbosch, and
N Lisin, and
M Andriange, and
J Gach, and
J Carlier
May 1983,
Praxis und Klinik der Pneumologie,
